Objectives: Mindfulness-based interventions (MBIs) have emerged as promising
prophylactic episodic migraine treatments. The present study investigated biopsychosocial
predictors and outcomes associated with formal, daily-life meditation practice in migraine
patients undergoing MBI, and whether augmented mindfulness mechanistically underlies
change. Methods: Secondary analyses of clinical trial comparing data 12-week mindfulness-based
stress reduction (MBSR+; n = 50) to stress management for headache (SMH; n = 48) were
conducted. Results: Pre-treatment mesocorticolimbic system functioning (i.e., greater resting
state ventromedial prefrontal cortex-right nucleus accumbens [vmPFC-rNAC] functional
connectivity) positively predicted meditation practice duration over MBSR+ (r = .58, p = .001),
and moderated change in headache frequency from pre to post-treatment (b = -12.60, p = .02)
such that patients with greater vmPFC-rNAC connectivity showed greater reductions in
headache frequency. Patients who meditated more showed greater increases in mindfulness (b =
.52, p = .02) and reductions in the helplessness facet of pain catastrophizing (b = -.13, p = .01),
but not headache frequency, severity or impact. Augmented mindfulness mediated reductions in
headache impact resulting from MBSR+, but not headache frequency. Conclusions:
Mesocorticolimbic system function is implicated in motivated behavior, and thus could be a
target of augmentative interventions designed to enhance meditation practice engagement.
Meditation practice appears to benefit pain-related cognitions, but not clinical pain, while
mindfulness emerges as a mechanism of MBIs on headache impact, but not frequency. Further
research is needed to investigate the day-to-day effects of meditation practice on pain, and
continue to characterize the specific mechanisms of MBIs on headache outcomes.